Literature DB >> 33760886

Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.

Sherry L Kurtz1, Roberto De Pascalis1, Anda I Meierovics1, Karen L Elkins1.   

Abstract

CCR2 is the major chemokine receptor that regulates appropriate trafficking of inflammatory monocytes, but the role of this chemokine receptor and its ligands during primary and secondary infection with intracellular infections remains incompletely understood. Here we used murine infection with the Live Vaccine Strain (LVS) of Francisella tularensis to evaluate the role of CCR2 during primary and secondary parenteral responses to this prototype intracellular bacterium. We find that mice deficient in CCR2 are highly compromised in their ability to survive intradermal infection with LVS, indicating the importance of this receptor during primary parenteral responses. Interestingly, this defect could not be readily attributed to the activities of the known murine CCR2 ligands MCP-1/CCL2, MCP-3/CCL7, or MCP-5/CCL12. Nonetheless, CCR2 knockout mice vaccinated by infection with low doses of LVS generated optimal T cell responses that controlled the intramacrophage replication of Francisella, and LVS-immune CCR2 knockout mice survived maximal lethal Francisella challenge. Thus, fully protective adaptive immune memory responses to this intracellular bacterium can be readily generated in the absence of CCR2.

Entities:  

Year:  2021        PMID: 33760886      PMCID: PMC7990183          DOI: 10.1371/journal.pone.0249142

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

1.  Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.

Authors:  Riccardo D'Elia; Dominic C Jenner; Thomas R Laws; Margaret G M Stokes; Matthew C Jackson; Angela E Essex-Lopresti; Helen S Atkins
Journal:  FEMS Immunol Med Microbiol       Date:  2011-06-16

2.  Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.

Authors:  Ana I Dueñas; Mónica Aceves; Antonio Orduña; Ramón Díaz; Mariano Sánchez Crespo; Carmen García-Rodríguez
Journal:  Int Immunol       Date:  2006-03-30       Impact factor: 4.823

3.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis.

Authors:  Meenakshi Malik; Chandra Shekhar Bakshi; Bikash Sahay; Aaloki Shah; Steven A Lotz; Timothy J Sellati
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes.

Authors:  Marcel Wüthrich; Karen Ersland; Thomas Sullivan; Kevin Galles; Bruce S Klein
Journal:  Immunity       Date:  2012-04-05       Impact factor: 31.745

Review 6.  The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines.

Authors:  Courtney E Bolger; Colin A Forestal; Jaime K Italo; Jorge L Benach; Martha B Furie
Journal:  J Leukoc Biol       Date:  2005-03-09       Impact factor: 4.962

7.  Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.

Authors:  Patrik Ryden; Susan Twine; Hua Shen; Gregory Harris; Wangxue Chen; Anders Sjostedt; Wayne Conlan
Journal:  Mol Immunol       Date:  2012-11-28       Impact factor: 4.407

8.  Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Authors:  Damiana Chiavolini; Joseph Alroy; Carol A King; Peter Jorth; Susan Weir; Guillermo Madico; John R Murphy; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

Review 9.  Innate and adaptive immunity to Francisella.

Authors:  Karen L Elkins; Siobhán C Cowley; Catharine M Bosio
Journal:  Ann N Y Acad Sci       Date:  2007-04-27       Impact factor: 5.691

10.  Francisella tularensis selectively induces proinflammatory changes in endothelial cells.

Authors:  Colin A Forestal; Jorge L Benach; Chateen Carbonara; Jaime K Italo; Tracy J Lisinski; Martha B Furie
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.